The Oncogene
MYCN
drug target
metabolism
microarray analysis
migration and combination therapy
pharmacological inhibition
retinoblastoma
shRNA knockdown
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
19 Oct 2021
19 Oct 2021
Historique:
received:
09
09
2021
revised:
11
10
2021
accepted:
12
10
2021
entrez:
23
10
2021
pubmed:
24
10
2021
medline:
24
10
2021
Statut:
epublish
Résumé
Retinoblastoma is usually initiated by biallelic
Identifiants
pubmed: 34680394
pii: cancers13205248
doi: 10.3390/cancers13205248
pmc: PMC8533785
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Indian Council of Medical Research
ID : 45/23/2019-BIO/BMS (S.S.)
Organisme : Department of Biotechnology
ID : BT/Bio-CARe/07/9859/2013-14 and BT/PR32404/MED/30/2136/2019 (M.M.R.)
Références
Cancers (Basel). 2020 Aug 16;12(8):
pubmed: 32824373
Biomark Med. 2018 Apr;12(4):393-402
pubmed: 29575908
Nature. 1986 Oct 16-22;323(6089):643-6
pubmed: 2877398
PLoS One. 2017 May 15;12(5):e0177744
pubmed: 28505181
J Surg Oncol. 2011 Dec;104(7):841-6
pubmed: 21721010
Cancer Res. 2015 Sep 15;75(18):3685-6
pubmed: 26374463
Pharmacol Rev. 2006 Sep;58(3):621-81
pubmed: 16968952
Cell. 2009 Jun 12;137(6):1018-31
pubmed: 19524506
Crit Rev Oncol Hematol. 2016 Sep;105:35-51
pubmed: 27375228
BMC Cancer. 2017 Jun 20;17(1):434
pubmed: 28633655
Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):16
pubmed: 33704359
Clin Transl Med. 2017 Nov 9;6(1):42
pubmed: 29124525
Signal Transduct Target Ther. 2018 Feb 23;3:5
pubmed: 29527331
Cell. 2011 Sep 16;146(6):904-17
pubmed: 21889194
Cold Spring Harb Perspect Med. 2013 Oct 01;3(10):a014415
pubmed: 24086065
Ophthalmology. 2020 Jun;127(6):804-813
pubmed: 32139107
Int J Oncol. 2014 Apr;44(4):1376-84
pubmed: 24452447
Symp Fundam Cancer Res. 1986;39:115-9
pubmed: 3480547
J Biol Chem. 2000 Jul 21;275(29):21797-800
pubmed: 10823814
Genes Chromosomes Cancer. 2007 Feb;46(2):118-29
pubmed: 17099872
Science. 1984 Jun 8;224(4653):1121-4
pubmed: 6719137
Cancer Discov. 2013 Mar;3(3):308-23
pubmed: 23430699
Exp Cell Res. 2019 Feb 15;375(2):92-99
pubmed: 30584916
Lancet Oncol. 2013 Apr;14(4):327-34
pubmed: 23498719
Genes (Basel). 2017 May 25;8(6):
pubmed: 28587062
Cancer Lett. 2017 May 28;394:76-87
pubmed: 28254412
Cancer Discov. 2013 May;3(5):512-9
pubmed: 23539269
BMC Cancer. 2016 Aug 04;16:597
pubmed: 27487789
J Clin Invest. 2017 Mar 1;127(3):888-898
pubmed: 28165337
Dev Biol. 1998 Mar 1;195(1):16-28
pubmed: 9520320
Mol Cancer Res. 2014 Jun;12(6):815-22
pubmed: 24589438
N Engl J Med. 1985 Oct 31;313(18):1111-6
pubmed: 4047115
Mol Cell Endocrinol. 2016 Aug 15;431:123-32
pubmed: 27173027
Cell. 2016 Jul 28;166(3):555-566
pubmed: 27471965
Cancer Control. 2004 Sep-Oct;11(5):317-27
pubmed: 15377991
Mol Cell Biol. 2004 Jul;24(13):5923-36
pubmed: 15199147
Clin Cancer Res. 2016 Sep 1;22(17):4452-65
pubmed: 27076630
Nature. 1984 May 31-Jun 6;309(5967):458-60
pubmed: 6728001
Oncogene. 2006 Aug 28;25(38):5233-43
pubmed: 16936742
J Clin Oncol. 2005 Feb 1;23(4):880-8
pubmed: 15681534
Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10258-63
pubmed: 23733953
Mol Cell Biol. 1993 Sep;13(9):5216-24
pubmed: 8395000
Oncotarget. 2016 Nov 15;7(46):74415-74426
pubmed: 27769070
Eur J Cancer. 1995;31A(4):516-9
pubmed: 7576956
Asian Pac J Cancer Prev. 2013;14(7):4107-13
pubmed: 23991961
PLoS One. 2014 May 23;9(5):e97285
pubmed: 24859015
Clin Exp Ophthalmol. 2014 Jan-Feb;42(1):33-52
pubmed: 24433356
Cell. 2012 Mar 30;149(1):22-35
pubmed: 22464321
J Cell Biochem. 2018 Jun;119(6):4717-4728
pubmed: 29274284
BMC Cancer. 2018 Oct 12;18(1):976
pubmed: 30314454
Cancers (Basel). 2020 Sep 22;12(9):
pubmed: 32971811
Curr Top Med Chem. 2018;18(6):444-453
pubmed: 29788890
Oncotarget. 2015 Mar 30;6(9):6670-83
pubmed: 25749384
Cold Spring Harb Perspect Med. 2013 Aug 01;3(8):
pubmed: 23906881
Br J Cancer. 2002 Sep 23;87(7):779-82
pubmed: 12232763
Breast Cancer Res Treat. 2020 Jul;182(2):267-282
pubmed: 32445177
Molecules. 2021 Apr 01;26(7):
pubmed: 33915740
Genes (Basel). 2017 Mar 30;8(4):
pubmed: 28358317
Neuro Oncol. 2009 Oct;11(5):477-87
pubmed: 19139420
Hum Mol Genet. 2008 May 15;17(10):1363-72
pubmed: 18211953
Oncotarget. 2014 Jan 30;5(2):438-50
pubmed: 24509483
Oncogene. 2020 Jul;39(31):5338-5357
pubmed: 32572160
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683